AGT and kidney disorder: Thus, in non-neoplastic renal diseases this peptide inhibits proinflammatory and profibrotic processes that lead to renal damage and ACEi and ARBs have local tissue effects restoring imbalances between Ang II/AT1 and Ang 1-7/Mas receptor axis [41,42].